Unknown

Dataset Information

0

The epigenetic regulator Mll1 is required for Wnt-driven intestinal tumorigenesis and cancer stemness.


ABSTRACT: Wnt/?-catenin signaling is crucial for intestinal carcinogenesis and the maintenance of intestinal cancer stem cells. Here we identify the histone methyltransferase Mll1 as a regulator of Wnt-driven intestinal cancer. Mll1 is highly expressed in Lgr5+ stem cells and human colon carcinomas with increased nuclear ?-catenin. High levels of MLL1 are associated with poor survival of colon cancer patients. The genetic ablation of Mll1 in mice prevents Wnt/?-catenin-driven adenoma formation from Lgr5+ intestinal stem cells. Ablation of Mll1 decreases the self-renewal of human colon cancer spheres and halts tumor growth of xenografts. Mll1 controls the expression of stem cell genes including the Wnt/?-catenin target gene Lgr5. Upon the loss of Mll1, histone methylation at the stem cell promoters switches from activating H3K4 tri-methylation to repressive H3K27 tri-methylation, indicating that Mll1 sustains stem cell gene expression by antagonizing gene silencing through polycomb repressive complex 2 (PRC2)-mediated H3K27 tri-methylation. Transcriptome profiling of Wnt-mutated intestinal tumor-initiating cells reveals that Mll1 regulates Gata4/6 transcription factors, known to sustain cancer stemness and to control goblet cell differentiation. Our results demonstrate that Mll1 is an essential epigenetic regulator of Wnt/?-catenin-induced intestinal tumorigenesis and cancer stemness.

SUBMITTER: Grinat J 

PROVIDER: S-EPMC7752919 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications


Wnt/β-catenin signaling is crucial for intestinal carcinogenesis and the maintenance of intestinal cancer stem cells. Here we identify the histone methyltransferase Mll1 as a regulator of Wnt-driven intestinal cancer. Mll1 is highly expressed in Lgr5<sup>+</sup> stem cells and human colon carcinomas with increased nuclear β-catenin. High levels of MLL1 are associated with poor survival of colon cancer patients. The genetic ablation of Mll1 in mice prevents Wnt/β-catenin-driven adenoma formation  ...[more]

Similar Datasets

| S-EPMC3775784 | biostudies-literature
| S-SCDT-EMBOR-2019-49229-T | biostudies-other
| S-EPMC7132202 | biostudies-literature
| S-EPMC5854208 | biostudies-literature
| S-EPMC6636642 | biostudies-literature
| S-EPMC8641872 | biostudies-literature
| S-EPMC6338624 | biostudies-literature
| S-EPMC5130037 | biostudies-literature
| S-EPMC7460588 | biostudies-literature
| S-EPMC9477743 | biostudies-literature